<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/895">
<title>ARTICOLE ȘTIINȚIFICE</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/895</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://repository.usmf.md:80/xmlui/handle/20.500.12710/9650"/>
<rdf:li rdf:resource="http://repository.usmf.md:80/xmlui/handle/20.500.12710/9646"/>
<rdf:li rdf:resource="http://repository.usmf.md:80/xmlui/handle/20.500.12710/9645"/>
<rdf:li rdf:resource="http://repository.usmf.md:80/xmlui/handle/20.500.12710/9433"/>
</rdf:Seq>
</items>
<dc:date>2026-04-13T19:45:03Z</dc:date>
</channel>
<item rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/9650">
<title>Tulburări din spectrul autist la copiii cu epilepsie</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/9650</link>
<description>Tulburări din spectrul autist la copiii cu epilepsie
Bejan, Nadejda; Hadjiu, Svetlana; Revenco, Ninel; Călcîi, Cornelia; Lupușor, Nadejda; Feghiu, Ludmila; Grîu, Corina; Andreev, Nastea; Tihai, Olga; Sprincean, Mariana
State University of Medicine and Pharmacy “Nicolae Testemitanu”&#13;
PMI Institute of Mother and Child, Chisinau, Republic of Moldova &#13;
The National Epileptology Center, Chişinău
</description>
<dc:date>2018-09-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/9646">
<title>Malformațiile congenitale cerebrale la copii: cosiderații clinico-genetice</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/9646</link>
<description>Malformațiile congenitale cerebrale la copii: cosiderații clinico-genetice
Tihai, Olga; Hadjiu, Svetlana; Sprincean, Mariana; Călcîi, Cornelia; Lupușor, Nadejda; Bejan, Nadejda; Revenco, Ninel
A 41-a Conferință Națională de Neurologie-Psihiatrie&#13;
şi Profesiuni Asociate a Copilului şi Adolescentului din România&#13;
cu participare internaţională / The 41st National Conference of Child and Adolescent&#13;
Neurology and Psychiatry and Associated Professions&#13;
with international participation.&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
Universitatea de Stat de Medicină şi Farmacie “N. Testemiţanu”,&#13;
IMSP Institutul Mamei şi Copilului, Chişinau, Republica Moldova,&#13;
IMSP Institute of Mother and Child, Chisinau, Republic of Moldova.
</description>
<dc:date>2018-09-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/9645">
<title>Calitatea vieții la copii cu accident vascular cerebral</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/9645</link>
<description>Calitatea vieții la copii cu accident vascular cerebral
Lupuşor, Nadejda; Hadjiu, Svetlana; Sprincean, Mariana; Călcîi, Cornelia; Feghiu, Ludmila; Grîu, Corina; Bejan, Nadejda; Tihai, Olga; Revenco, Ninel
Introducere: Accidentul vascular cerebral pediatric&#13;
reprezintă o urgență majoră și o problemă importantă&#13;
de sănătate, fiind o cauză majoră a invalidității dobândite în copilărie. Deși supraviețuirea în caz de&#13;
AVC este un indicator cheie, calitatea vieții este o&#13;
caracteristică importantă pentru supraviețuitori și&#13;
oferă informații despre modul în care tratamentul și&#13;
complicațiile AVC afectează copilul și capacitatea sa&#13;
de funcționare în mediul de acasă, școală și comunitate.&#13;
Lucrarea de față ca scop analiza calității vieții&#13;
copiilor cu AVC pe baza unei sinteze a literaturii&#13;
de specialitate. Ulterior se preconizează și un studiu&#13;
practic.; Introduction: Pediatric stroke is a significant&#13;
emergency and an important health problem, being&#13;
a major cause of acquired disability in childhood.&#13;
Although survival is an outcome key indicator,&#13;
quality of life is an important outcome in survivors. It&#13;
provides information about how treatment and stroke&#13;
complications affect the child and his/her ability&#13;
to function within home, school, and community&#13;
environment.&#13;
This paper’s aim is to analyze the quality of life of&#13;
children with stroke based on a synthesis of literature.&#13;
A practical study is also expected for the future.
A 41-a Conferință Națională de Neurologie-Psihiatrie şi Profesiuni Asociate a Copilului şi Adolescentului din România cu participare internaţională / The 41st National Conference of Child and Adolescent Neurology and Psychiatry and Associated Professions with international participation.&#13;
&#13;
&#13;
IMSP Institutul Mamei şi Copilului, Chișinău,&#13;
Centrul Național de Epileptologie, Chișinău,&#13;
State University of Medicine and Pharmacy “Nicolae Testemitanu” Chisinau, Republic of Moldova ,&#13;
PMI Institute of Mother and Child, Chișinău&#13;
The National Epileptology Center, Chișinău
</description>
<dc:date>2018-09-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/9433">
<title>Managementul convulsiilor la copil: protocol clinic</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/9433</link>
<description>Managementul convulsiilor la copil: protocol clinic
Current relevance of the study. Convulsions are a transient event characterized by signs and/or clinical symptoms&#13;
due to an excessive and hypersynchronous activity of a group of cerebral neurons in the gray matter, with or without&#13;
loss of consciousness, being detected by EEG.&#13;
The purpose of the study is to develop a clinical protocol for seizure management in children.&#13;
Materials and methods: The study was based on the research of literature data.&#13;
Results. The therapeutic approach to acute seizures is based on the reevaluation and monitoring of vital signs and&#13;
neurological status continuously within the fi rst 6-12 hours after the seizure (with exception of simple febrile seizures);&#13;
observance of the principles of pharmaceutical anticonvulsant treatment, i. e., rapid administration of anticonvulsant&#13;
medication (MAE), using a correct dose of MAE, observing correct administration, it is advisable to avoid low and&#13;
frequent doses or insuffi cient individual doses, as these drugs can prolong the time at which the therapeutic level is&#13;
reached, after each dose of MAE, status monitoring is performed every 5 minutes while the seizures continues and every&#13;
15 minutes after a seizures ceased, until the level of consciousness returns to normal, and in proper time can be made&#13;
decision to change the therapy for more effective scheme. The most common errors in the treatment of the patient with&#13;
convulsions are using sub effective dose, wrong choice of medication, wrong choice of route of administration.&#13;
Conclusions: In the case of seizures it is important to recognize this situation, to provide emergency help by positioning the child, administering anti-epileptic treatment, to request of the competent services, to ensure supervision of&#13;
the child by neuropediatrician, to administer anti-epileptic drugs in the event of a recurrence of seizures, and, if necessary, to request the UPU service.&#13;
&#13;
&#13;
&#13;
Актуальность исследования. Судороги являются приступами преходящего характера, характеризующиеся признаками и / или клиническими симптомами, вызванными избыточной гиперсинхронной деятельностью&#13;
группы нейронов в коре серого вещества головного мозга, с или без потери сознания, которые обнаруживается с помощью ЭЭГ.&#13;
Целью исследования является разработка клинического протокола для лечения судорог у детей.&#13;
Материал и методы. Исследование основано на исследовании литературных данных.&#13;
Результаты. Лечение острых судорожных приступов основано на оценке и маненжменте функций жизненно важных органов и непрерывного неврологического наблюдения в течение первых 6-12 часов после судорожного приступа (за исключением: простых фебрильных судорог); соблюдение принципов противосудорожной лекарственной терапии: быстрое введение лекарственных антиконвульсивных препаратов (МАЕ),&#13;
использование правильной дозы МАЕ, соблюдая при этом правильного режима администрирования, введение&#13;
препарата должным образом, следует избегать низких и частых доз или недостаточных индивидуальных доз&#13;
(это может продлить время достижения терапевтического уровня препарата), наблюдение состояния ребенка после каждой дозы MAE каждые 5 минут, пока приступ продолжается, и каждые 15 минут после кризиса, пока уровень сознания не вернется к норме, решение перейти к другой линии терапии будет приниматься своевременно. Наиболее распространенные ошибки в лечении пациента с судорогами являются следующие:&#13;
недостаточная дозировка препарата, чрезмерная дозировка, неправильный выбор лекарств, неправильный выбор пути введения. Выводы: В случае судорог важно распознать припадок, предоставить экстренную помощь ребенку, правильно позиционировать его, обеспечить введение противоэпилептического препарата своевременно, запрасить&#13;
компетентную помощь, обеспечить наблюдение за ребенком нейропедитром, назначить противосудорожный&#13;
препарат в случае повторяющегося приступа, запросить службы экстренной помощи в случае необходимости.
Universitatea de Stat de Medicină şi Farmacie “Nicolae Testemiţanu”,&#13;
Departamentul Pediatrie &#13;
&#13;
 IMSP Institutul Mamei şi Copilului
</description>
<dc:date>2018-01-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
